Historical overview of vitamin D

Vitamin D

Volumn , Issue , 2011, Pages 3-12

  Deluca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863871167     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10001-0     Document Type: Chapter

References (127)

1. Von Liebig J. Animal Chemistry or Organic Chemistry in Its Application to Physiology and Pathology. A History of Nutrition by McCollum EV 1957, The Riverside Press, Cambridge, Massachusetts. H.B. Glass (Ed.).
2. Lunin N. Uber di bedeuting der anorganischen salze fu die ernahrung des tieres. Z. Physiol. Chem. 1881, 5:31-39.
3. Hopkins G. Feeding experiments illustrating the importance of accessory food factors in normal dietaries. J. Physiol. 1912, 44:425-460.
4. Magendie F. Ann Chim. Phys. 3. A History of Nutrition by McCollum EV 1816, 86-87. The Riverside Press, Cambridge Massachusetts, (1957). H.B. Glass (Ed.).
5. Funk C. The chemical nature of the substance that cures polyneuritis in birds produced by a diet of polished rice. J. Physiol. (London) 1911, 43:395-402.
6. Eijkman C. Ein beri-beri anliche der huhner. Virchow.'s. Arch. 1897, 148:523-527.
7. Grijns G. Concerning polyneuritis geneeskundig gallinarum tijschrift voor ned indie 1901. A History of Nutrition 1957, 216. Hough ton Mifflin, Boston, Massachusetts. E.V. McCollum, H.B. Glass (Eds.).
8. Holst A., Frolich T. Experimental studies relating ship-beriberi to scurvy. II. On the etiology of scurvy. J. Hyg. 1907, 7:634-671.
9. Hart E.B., McCollum E.V., Steenbock H., Humphrey G.C. Physiological effect on growth and reproduction of rations balanced from restricted sources. Wis. Agric. Exp. Sta. Res. Bull. 1911, 17:131-205.
10. McCollum E.V., Davis M. The necessity of certain lipins in the diet during growth. J. Biol. Chem. 1913, 25:167-175.
11. McCollum E.V., Simmons N., Pitz W. The relation of the unidentified dietary factors, the fat-soluble A and water-soluble B of the diet to the growth promoting properties of milk. J. Biol. Chem. 1916, 27:33-38.
12. Osborne T.B., Mendel L.B. The role of vitamines in the diet. J. Biol. Chem. 1917, 31:149-163.
13. Whistler D. De morbo puerli anglorum, quem patrio ideiomate indigenae vocant "the rickets" (lugduni, batavorum 1645). As cited by Smerdon GT, Daniel Whistler and the English Disease. A translation and biographical note. J. Hist. Med. 1950, 5:397-415.
14. Hess A. The history of rickets. Rickets, Including Osteomalacia and Tetany 1929, 22-37. Lea & Febiger, Philadelphia, Pennsylvania.
15. Mellanby E. An experimental investigation on rickets. Lancet 1919, 1:407-412.
16. McCollum E.V., Simmonds N., Becker J.E., Shipley P.G. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J. Biol. Chem. 1922, 53:293-298.
17. Huldshinsky K. Heilung von rachitis durch kunstalich hohen-sonne. Deut. Med. Wochenschr. 1919, 45:712-713.
18. Chick H., Palzell E.J., Hume E.M. Studies of rickets in Vienna 1919-1922. Medical Research Council, Special Report No. 1923, 77.
19. Steenbock H., Hart E.B. The influence of function on the lime requirements of animals. J. Biol. Chem. 1913, 14:59-73.
20. Steenbock H., Black A. Fat-soluble vitamins. XVII. The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light. J. Biol. Chem. 1924, 61:405-422.
21. Hess A.F., Weinstock M. Antirachitic properties imparted to lettuce and to growing wheat by ultraviolet irradiation. Proc. Soc. Exp. Biol. Med. 1924, 22:5-6.
22. Steenbock H., Black A. Fat-soluble vitamins. XXIII. The induction of growth-promoting and calcifying properties in fats and their unsaponifiable consituents by exposure to light. J. Biol. Chem. 1925, 64:263-298.
23. Windaus A., Linsert O. 1928 Vitamin D1. Ann. Chem. 1928, 465:148.
24. Askew F.A., Bourdillon R.B., Bruce H.M., Jenkins R.G.C., Webster T.A. The distillation of vitamin D. Proc. R. Soc. 1931, 8107:76-90.
25. 2. Ann. Chem. 1932, 492:226-241.
26. Windaus A., Bock F. Uber das provitamin aus dem sterin der schweineschwarte. Z. Physiol. Chem. 1937, 245:168-170.
27. Windaus A., Lettre H., Schenck F. 7-Dehydrocholesterol. Ann. Chem. 1935, 520:98-107.
28. Windaus A., Schenck F., von Werder F. Uber das antirachitisch wirksame bestrahlungs-produkt aus 7-dehydrocholesterin, Hoppe.-Seylers. Z. Physiol. Chem. 1936, 241:100-103.
29. 3 from rat skins irradiated in vitro with ultraviolet light. Arch. Biochem. Biophys. 1978, 188:282-286.
30. 3 in human skin and the physiologic consequences. Science 1980, 210:203-205.
31. Orr W.J., Holt L.E., Wilkins L., Boone F.H. The calcium and phosphorus metabolism in rickets, with special reference to ultraviolet rat therapy. Am. J. Dis. Children 1923, 26:362-372.
32. Kletzien S.W.F., Templin V.M., Steenbock H., Thomas B.H. Vitamin D and the conservation of calcium in the adult. J. Biol. Chem. 1932, 97:265-280.
33. Nicolaysen R. Studies upon the mode of action of vitamin D. III. The influence of vitamin D on the absorption of calcium and phosphorus in the rat. Biochem. J. 1937, 31:122-129.
34. Nicolaysen R., Eeg-Larsen N., Malm O.J. Physiology of calcium metabolism. Physiol. Rev. 1953, 33:424-444.
35. 3: Nicolaysen's endogenous factor. Endocrinology 1971, 468-476. Heinemann Medical Books, London. S. Taylor (Ed.).
36. Ribovich M.L., DeLuca H.F. The influence of dietary calcium and phosphorus on intestinal calcium transport in rats given vitamin D metabolites. Arch. Biochem. Biophys. 1975, 170:529-535.
37. Rowland J., Kramer B. Calcium and phosphorus in the serum in relation to rickets. Am. J. Dis. Children 1921, 22:105-119.
38. Lamm M., Neuman W.F. On the role of vitamin D in calcification. Arch. Pathol. 1958, 66:204-209.
39. Underwood J.L., DeLuca H.F. Vitamin D is not directly necessary for bone growth and mineralization. Am. J. Physiol. 1984, 246:E493-E498.
40. DeLuca H.F. Mechanism of action and metabolic fate of vitamin D. Vit. Horm. 1967, 25:315-367.
41. Carlsson A. Tracer experiments on the effect of vitamin D on the skeletal metabolism of calcium and phosphorus. Acta. Physiol. Scand. 1952, 26:212-220.
42. Bauer G.C.H., Carlsson A., Lindquist B. Evaluation of accretion, resorption, and exchange reactions in the skeleton. Kungl Fysiograf Sallskapets I. Lund. Forhandlingar 1955, 25:3-18.
43. 3. Proc. Natl. Acad. Sci. USA 1968, 61:1503-1506.
44. 3. J. Bone. Miner. Res. 1999, 14:1478-1485.
45. 3 in thyroparathyroidectomized rats. Endocrinology 1974, 94:1022-1027.
46. Raisz L.G., Trummel C.L., Holick M.F., DeLuca H.F. 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 1972, 175:768-769.
47. Frost H.M. Bone dynamics in osteoporosis and osteomalacia 1966, Henry Ford Hospital Surgical Monograph Series, Thomas, Springfield, Illinois.
48. Yamamoto M., Kawanobe Y., Takahashi H., Shimazawa E., Kimura S., Ogata E. Vitamin D deficiency and renal calcium transport in the rat. J. Clin. Invest. 1984, 74:507-513.
49. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979, 206:1188-1190.
50. 2 vitamin D3 identified by thaw-mount autoradiography. Hormonal Control of Calcium Metabolism 1981, 222-229. Excerpta Medica, Amsterdam. D.V. Cohn, R.V. Talmage, J.L. Matthews (Eds.).
51. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 13 1992, 66-80.
52. 3 in the myeloid cell differentiation. Proc. Soc. Exp. Biol. Med. 1992, 91:214-220.
53. 3. Proc. Natl. Acad. Sci. USA 1992, 89:8097-8101.
54. 3 and its analogues. Their therapeutic usefulness in secondary hyperparathyroidism. Vitamin D and its Analogues. The Second International Forum on Calcified Tissue and Bone Metabolism 1994, Chugai Pharmaceutical, Tokyo, pp. 60-63.
55. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J. Invest. Dermatol. 1986, 86:709-714.
56. Kodicek E. Metabolic studies on vitamin D. Ciba Foundation Symposium on Bone Structure and Metabolism 1956, 161-174. Little, Brown, and Co., Boston, Massachusetts. G.W.E. Wolstenholme, C.M. O'Connor (Eds.).
57. Kodicek E. The metabolism of vitamin D. Proceedings of the Fourth International Congress of Biochemistry 1960, Vol. 11:198-208. Pergamon, London. W. Umbreit, H. Molitor (Eds.).
58. 3. Arch. Biochem. Biophys. 1967, 118:145-153.
59. 3 and the tissue localization of a 0.25 μg (10 IU) dose per rat. Biochemistry 1966, 5:2201-2207.
60. 3 from bone, liver, and blood serum. J. Lipid. Res. 1966, 7:739-744.
61. Morii H., Lund J., Neville P.F., DeLuca H.F. Biological activity of a vitamin D metabolite. Arch. Biochem. Biophys. 1967, 120:508-512.
62. 3. Biochemistry 1968, 7:3317-3322.
63. 3. Biochemistry 1969, 8:671-675.
64. DeLuca H.F. Metabolism and function of vitamin D. The Fat-Soluble Vitamins 1970, 3-20. Univ. of Wisconsin Press, Madison. H.F. DeLuca, J.W. Suttie (Eds.).
65. Lawson D.E.M., Wilson P.W., Kodicek E. Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-l, in chick intestinal nuclei. Biochem. J. 1969, 115:269-277.
66. 3 with intestinal mucosa chromatin in vivo. J. Biol. Chem. 1968, 243:4055-4064.
67. Myrtle J.F., Haussler M.R., Norman A.W. Evidence for the biologically active form of cholecalciferol in the intestine. J. Biol. Chem. 1970, 245:1190-1196.
68. Holick M.F., Schnoes H.K., DeLuca H.F., Suda T., Cousins R.J. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 1971, 10:2799-2804.
69. Fraser D.R., Kodicek E. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 1970, 228:764-766.
70. 3. Tetrahedron. Lett. 1972, 40:4147-4150.
71. 3. J. Chem. Soc. Chem. Commun. 1977, 890-892.
72. 3. Science 1973, 180:190-191.
73. Boyle I.T., Miravet L., Gray R.W., Holick M.F., DeLuca H.F. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology 1972, 90:605-608.
74. 3 active on bone in anephric rats. Science 1972, 176:1146-1147.
75. Wong R.G., Norman A.W., Reddy C.R., Coburn J.W. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. J. Clin. Invest. 1972, 51:1287-1291.
76. Fraser D., Kooh S.W., Kind H.P., Holick M.F., Tanaka Y., DeLuca H.F. Pathogenesis of hereditary vitamin D dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N. Engl. J. Med. 1973, 289:817-822.
77. Boyle I.T., Gray R.W., DeLuca H.F. Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol. Proc. Natl. Acad. Sci. USA 1971, 68:2131-2134.
78. Garabedian M., Holick M.F., DeLuca H.F., Boyle I.T. Control of 25-hydroxycholecalciferol metabolism by the parathyroid glands. Proc. Natl. Acad. Sci. USA 1972, 69:1673-1676.
79. Fraser D.R., Kodicek E. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nature (New. Biol.) 1973, 241:163-166.
80. Tanaka Y., DeLuca H.F. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch. Biochem. Biophys. 1973, 154:566-574.
81. 3 1- and 24-hydroxylases: their in vivo regulation. Am. J. Physiol. 1984, 246:E168-E173.
82. Chen T.C., Castillo L., DeLuca H.F. Role of vitamin D metabolites in phosphate transport of rat intestine. J. Nutr. 1974, 104:1056-1060.
83. 3 on active intestinal inorganic phosphate absorption. Vitamin D: Biochemical, Chemical, and Clinical Aspects Related to Calcium Metabolism 1977, 321-330. Walter de Gruyter, Berlin. A.W. Norman, K. Schaefer, J.W. Coburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, D. von Herrath (Eds.).
84. Berndt T., Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Ann. Rev. Physiol. 2007, 69:4.1-4.19.
85. 3 preferentially active on bone. Biochemistry 1970, 9:2917-2922.
86. 3 with intestinal calcium transport activity. Biochemistry 1970, 9:4776-4780.
87. 3. Biochemistry 1975, 14:3293-3296.
88. DeLuca H.F., Schnoes H.K. Vitamin D: recent advances. Annu. Rev. Biochem. 1983, 52:411-439.
89. 3. Endocr. Rev. 1985, 6:491-511.
90. Brommage R., Jarnagin K., DeLuca H.F., Yamada S., Takayama H. 1- But not 24-hydroxylation of vitamin D is required for skeletal mineralization in rats. Am. J. Physiol. 1983, 244:E298-E304.
91. 3: biological activity in the rat. Arch. Biochem. Biophys. 1982, 218:134-141.
92. 3 and its lα-hydroxy derivative. Arch. Biochem. Biophys. 1985, 241:173-178.
93. 3 1α-hydroxylase. Biochem. Biophys. Res. Commun. 1997, 239:527-533.
94. 3-24-hydroxylase, a multicatalytic enzyme. Biochemistry 1996, 35:8465-8472.
95. St-Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.
96. 3 in vitamin D receptor-ablated mice in vivo. Biochemistry 2000, 39:2123-2129.
97. 3. Biochemistry 1979, 18:3977-3983.
98. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 2003, 278:38084-38093.
99. Zull J.E., Czarnowska-Misztal E., DeLuca H.F. Actinomycin D inhibition of vitamin D action. Science 1965, 149:182-184.
100. Eisenstein R., Passavoy M. Actinomycin D inhibits parathyroid hormone and vitamin D activity. Proc. Soc. Exp. Biol. Med. 1964, 117:77-79.
101. 3 receptor: competitive binding of vitamin D analogs. Life. Sci. 1973, 13:1737-1746.
102. 3. Arch. Biochem. Biophys. 1976, 176:779-787.
103. McDonnell D.P., Mangelsdorf D.J., Pike J.W., Haussler M.R., O'Malley B.W. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987, 235:1214-1217.
104. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 1988, 85:3294-3298.
105. 3 receptor cDNA. Proc. Natl. Acad. Sci. USA 1988, 85:1005-1009.
106. 3 receptor. Proc. Natl. Acad. Sci. USA 1988, 85:9499-9502.
107. Miyamoto K., Kesterson R.A., Yamamoto H., Nishiwaki E., Tatsumi S., Taketani Y., et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endo. 1997, 11:1165-1179.
108. Jehan F., DeLuca H.F. Cloning and characterization of the mouse vitamin D receptor promoter. Proc. Natl. Acad. Sci. USA 1997, 94:10138-10143.
109. Jehan F., DeLuca H.F. The mouse vitamin D receptor is mainly expressed through an Sp1-driven promoter in vivo. Arch. Biochem. Biophys. 2000, 377:273-283.
110. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
111. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
112. Brooks M.H., Bell N.H., Love L., Stern P.H., Orfei E., Queener S.F., et al. Vitamin D-dependent rickets Type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 1978, 298:996-999.
113. Hughes M.R., Malloy P.J., Kieback D.G., Kesterson R.A., Pike J.W., Feldman D., et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988, 242:1702-1706.
114. Wiese R.J., Goto H., Prahl J.M., Marx S.J., Thomas M., Al-Aqeel A., et al. Vitamin D-dependency rickets Type II: truncated vitamin D receptor in three kindreds. Mol. Cell. Endocrinol. 1993, 90:197-201.
115. 3. Proc. Natl. Acad. Sci. USA 1990, 87:369-373.
116. 3 enhancement of mouse secreted phosphoprotein 1 (Spp1, osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 1990, 87:9995-9999.
117. 3. Proc. Natl. Acad. Sci. USA 1992, 89:8097-8101.
118. Zierold C., Darwish H.M., DeLuca H.F. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem. 1995, 270:1675-1678.
119. 3 receptors. Cell 1991, 65:1255-1266.
120. Yu V.C., Delsert C., Andersen B., Holloway J.M., Devary O.V., Naar A.M., et al. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991, 67:1251-1266.
121. Munder M., Herzberg I.M., Zierold C., Moss V.E., Hanson K., Clagett-Dame M., et al. Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor. Proc. Natl. Acad. Sci. USA 1995, 93:2796-2799.
122. Jin C.H., Pike J.W. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol. Endo. 1996, 10:196-205.
123. DiRenzo J., Soderstrom M., Kurokawa R., Ogliastro M.-H., Ricote M., Ingrey S., et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 1997, 17:2166-2176.
124. 3 and calcium. Proc. Natl. Acad. Sci. USA 2003, 100:9733-9737.
125. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995, 136:1419-1425.
126. 3. Mol. Endocrinol. 2006, 20:1231-1247.
127. 3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 2006, 26:6469-6486.